AtaiBeckley (ATAI) Liabilities and Shareholders Equity (2020 - 2026)

AtaiBeckley's (ATAI) quarterly Liabilities and Shareholders Equity came in at $264.9 million in Q1 2026, down 9.51% quarter-over-quarter from $292.7 million in Q4 2025.

AtaiBeckley (ATAI) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

AtaiBeckley's Liabilities and Shareholders Equity history runs 3 years deep, the most recent figure standing at $264.9 million for Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity changed N/A year-over-year to $264.9 million in Q1 2026; TTM through Mar 2026 was $717.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $292.7 million, up 83.66% from the prior year.
  • Liabilities and Shareholders Equity retreated to $264.9 million in Q1 2026 per ATAI's latest filing, from $292.7 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $342.6 million in Q3 2022 to a low of $885000.0 in Q1 2021.
  • A 5-year average of $178.6 million and a median of $239.8 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
  • Biggest YoY gain for Liabilities and Shareholders Equity was 83.66% in 2025; the steepest drop was 83.66% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $159.4 million in 2024, then jumped by 83.66% to $292.7 million in 2025, then slipped by 9.51% to $264.9 million in 2026.
  • Per Business Quant, the three latest ATAI Liabilities and Shareholders Equity figures stand at $264.9 million (Q1 2026), $292.7 million (Q4 2025), and $159.4 million (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 311.58 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 78.88 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 8.55 Bn
4 NuCana 279.75 Bn 279.75 Bn - 39.68 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 26.48 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 40.87 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 811.27 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 10.03 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.25 Bn
10 AtaiBeckley 2.56 Bn 2.56 Bn - 239.82 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 264.88 Mn
Dec 31, 2025 292.72 Mn
Sep 30, 2025 239.82 Mn
Mar 31, 2025 3.30 Mn
Dec 31, 2024 159.39 Mn
Dec 31, 2024 159.39 Mn
Jun 30, 2024 215.78 Mn
Mar 31, 2024 269.12 Mn
Dec 31, 2023 293.48 Mn
Sep 30, 2023 308.22 Mn
Jun 30, 2023 253.60 Mn
Mar 31, 2023 280.72 Mn
Dec 31, 2022 305.44 Mn
Sep 30, 2022 342.60 Mn
Dec 31, 2021 4.76 Mn
Sep 30, 2021 885,000.00
Jun 30, 2021 885,000.00
Mar 31, 2021 885,000.00
Dec 31, 2020 12.31 Mn